What Does Bicara Therapeutics CEO Sale Signal Investors
When a biotech CEO sells shares after exercising options, investors rightly pause to interpret the move. This article...
Stock index values update on scheduled times or upon data arrivals, varying by index and exchange. This piece covers the timing and implications.
22,965 articlesWhen a biotech CEO sells shares after exercising options, investors rightly pause to interpret the move. This article...
As Bitcoin prices turned volatile, Strategy—formerly MicroStrategy—pushed a high-stakes financing strategy that boost...
Can Nvidia keep leading in AI and data centers through 2030? This in-depth look lays out three scenarios, key drivers...
Tesla shares slipped as three major developments tug the stock in mixed directions: stricter autonomous driving overs...
When memory stocks surged on AI demand, one bold strategic move stood out. This article explains how micron just elim...
When a top executive sells stock, the market takes notice. This deeper look at Bristow Group's just sold helps you se...
Two consumer stars with very different paths battle for investors' attention. One mixes health-forward fast-casual ex...
Micron shares slid about 4% in early trading even after the company posted a robust quarterly report and raised its f...
NovaCore Technologies enters the second half of 2026 with a multi-year backlog, AI revenue momentum, and cloud growth...
Is intuitive surgical right now? The robotics leader faces macro headwinds and strong long term demand. This guide br...
Tesla’s latest delivery numbers surprised many investors. Despite solid growth, the stock moved lower as analysts wei...
Unisys (UIS) 2026 earnings could hinge on services growth, margin discipline, and backlog strength. This guide breaks...